ETHOS Health Communications, a Pennsylvania-based medical communications agency specializing in interpreting and communicating the innovative science and data for cutting-edge therapies, announced a name change to PRECISIONscientia.
Company to focus on pipeline of Pentarins™ as a unique and promising approach to treating solid tumor cancers Lead drug candidate PEN-221 targeting neuroendocrine and small cell lung cancers to […]
Reflecting Their Broader Scope of Research and Development, Sanguine Corp. Inc. Obtains Shareholder Approval to Change Name to New Alliance BioSciences ATLANTA, GA–(Marketwired – June 26, 2015) – Sanguine Corp., […]